
Please try another search
SkinBioTherapeutics plc is a United Kingdom-based life sciences company, which is focused on skin health. The principal activity of the Company and its subsidiaries is the identification and development of technology that harnesses the human microbiome to improve health. The Company's platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company is targeting five specific skin healthcare sectors, such as cosmetics skincare, food supplements for the treatment of skin conditions, medical skin care, infection control in both the home and the hospital environment, and pharmaceuticals for the prescribed treatment of skin conditions. The Company's product, AxisBiotix-Ps, is a food supplement to address the symptoms of mild to moderate psoriasis. The Company is also focused on the application of the SkinBiotix technology in the treatment of various classes of skin wounds.
Name | Age | Since | Title |
---|---|---|---|
Stuart John Ashman | 55 | 2019 | CEO & Executive Director |
Martin Braddock Hunt | 63 | 2016 | Independent Non-Executive Chairman |
Catherine Prescott | - | 2017 | Independent Non-Executive Director |
Catherine O'Neill | - | 2016 | Chief Scientific Officer & Member of Scientific Advisory Board |
Danielle Bekker | 46 | 2022 | Non-Executive Director |
Manprit Singh Randhawa | 39 | 2022 | CFO, Secretary & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review